(Q38950381)

7 September 2017

title

Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress (English)

1 reference

7 September 2017

1 reference

Y Chen

1

1 reference

7 September 2017

Z Zhang

2

1 reference

7 September 2017

K Yang

3

1 reference

7 September 2017

J Du

4

1 reference

7 September 2017

Y Xu

5

1 reference

7 September 2017

S Liu

6

1 reference

7 September 2017

language of work or name

English

0 references

publication date

6 October 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

29

1 reference

7 September 2017

page(s)

3839-3847

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2014.310

7 September 2017

exact match

0 references

cites work

Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

PKCalpha expression regulated by Elk-1 and MZF-1 in human HCC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Mzf1 controls cell proliferation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

A novel mammalian iron-regulated protein involved in intracellular iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Ferroportin-mediated iron transport: expression and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Induction of FPN1 transcription by MTF-1 reveals a role for ferroportin in transition metal efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Balancing acts: molecular control of mammalian iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

DNA helicase and helicase-nuclease enzymes with a conserved iron-sulfur cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Iron deprivation in cancer--potential therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Break-induced replication occurs by conservative DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Short RNAs repress translation after initiation in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Environmental and occupational causes of cancer: new evidence 2005-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Obesity and prostate cancer: epidemiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Nutrigenetics and prostate cancer: 2011 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Does iron have a role in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Body iron stores and the risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

An iron regulatory gene signature predicts outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Iron and cancer: more ore to be mined

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Disordered hepcidin-ferroportin signaling promotes breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Critical roles for c-Myb in lymphoid priming and early B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Transcription factor AP4 modulates reversible and epigenetic silencing of the Cd4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

The c-MYC-AP4-p21 cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

AP4 encodes a c-MYC-inducible repressor of p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

A mammalian microRNA expression atlas based on small RNA library sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Diagnostic and prognostic microRNAs in stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Body iron stores and risk of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.310

Ferroportin and iron regulation in breast cancer progression and prognosis

31 March 2020

1 reference

12 December 2020

p55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation

1 reference

12 December 2020

Iron-sulfur cluster proteins: electron transfer and beyond.

1 reference

12 December 2020

A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells

1 reference

12 December 2020

Forced over-expression of the myeloid zinc finger gene MZF-1 inhibits apoptosis and promotes oncogenesis in interleukin-3-dependent FDCP.1 cells.

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2014.310

1 reference

Dimensions Publication ID

7 September 2017

1005992844

0 references

1 reference